A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides
Open Access
- 28 January 2009
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (4), 918-929
- https://doi.org/10.1523/jneurosci.3952-08.2009
Abstract
Nicotinic acetylcholine receptors (nAChRs) containing α7 subunits are thought to assemble as homomers. α7-nAChR function has been implicated in learning and memory, and alterations of α7-nAChR have been found in patients with Alzheimer9s disease (AD). Here we report findings consistent with a novel, naturally occurring nAChR subtype in rodent, basal forebrain cholinergic neurons. In these cells, α7 subunits are coexpressed, colocalize, and coassemble with β2 subunit(s). Compared with homomeric α7-nAChRs from ventral tegmental area neurons, functional, presumably heteromeric α7β2-nAChRs on cholinergic neurons freshly dissociated from medial septum/diagonal band (MS/DB) exhibit relatively slow kinetics of whole-cell current responses to nicotinic agonists and are more sensitive to the β2 subunit-containing nAChR-selective antagonist, dihydro-β-erythroidine (DHβE). Interestingly, presumed, heteromeric α7β2-nAChRs are highly sensitive to functional inhibition by pathologically relevant concentrations of oligomeric, but not monomeric or fibrillar, forms of amyloid β1–42 (Aβ1–42). Slow whole-cell current kinetics, sensitivity to DHβE, and specific antagonism by oligomeric Aβ1–42 also are characteristics of heteromeric α7β2-nAChRs, but not of homomeric α7-nAChRs, heterologously expressed in Xenopus oocytes. Moreover, choline-induced currents have faster kinetics and less sensitivity to Aβ when elicited from MS/DB neurons derived from nAChR β2 subunit knock-out mice rather than from wild-type mice. The presence of novel, functional, heteromeric α7β2-nAChRs on basal forebrain cholinergic neurons and their high sensitivity to blockade by low concentrations of oligomeric Aβ1–42 suggests possible mechanisms for deficits in cholinergic signaling that could occur early in the etiopathogenesis of AD and might be targeted by disease therapies.Keywords
This publication has 54 references indexed in Scilit:
- Role of endogenous nicotinic signaling in guiding neuronal developmentBiochemical Pharmacology, 2007
- Pharmacological and immunological identification of native α7 nicotinic receptors: Evidence for homomeric and heteromeric α7 receptorsLife Sciences, 2007
- Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection proceduresJournal of Neurochemistry, 2007
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanismsJournal of Neural Transmission, 2006
- Subtype‐specific actions of β‐amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (α7, α4β2, α3β4) expressed in Xenopus laevis oocytesBritish Journal of Pharmacology, 2005
- β-Amyloid Directly Inhibits Human α4β2-Nicotinic Acetylcholine Receptors Heterologously Expressed in Human SH-EP1 CellsJournal of Biological Chemistry, 2004
- β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus OocytesJournal of Biological Chemistry, 2002
- Accelerated Plaque Accumulation, Associative Learning Deficits, and Up-regulation of α7 Nicotinic Receptor Protein in Transgenic Mice Co-expressing Mutant Human Presenilin 1 and Amyloid Precursor ProteinsPublished by Elsevier ,2002
- Nicotine Reduces the Secretion of Alzheimer's β‐Amyloid Precursor Protein Containing β‐Amyloid Peptide in the Rat without Altering Synaptic ProteinsAnnals of the New York Academy of Sciences, 2002